Beaujon Radiology

Alone we go faster, together we go further

[Maxime Ronot @maximeronot]

CT to raise suspicion of Porto-Sinusoidal Vascular Disorder (PSVD)

✅Liver Surface Nodularity < 2.5
➕
✅ No atrophy of segment 4

👉 > 90% specificity for PSVD

@HEP_Journal @RautouE @jcgarciapagan
https://t.co/ao6AFCXnzA

[Maxime Ronot @maximeronot]

Watching the never ending list of "impact of Covid-19 on ..." papers I'm surprised we don't already have the "impact of Covid-19 on the management of patients with Covid-19" study...

[Maxime Ronot @maximeronot]

HUGE update of the @BCLC_group in @JHepatology @ma5RN @Alexfornergon @bruixj @JordiRimola @docamitgs @riadsalemIR

✅Better pts characterization (BCLC-B ++)
✅Help for clinical decision making
✅ Radioembolization does exist!
✅ BCLC progression algo

https://t.co/6umjFVzdhy

[Maxime Ronot @maximeronot]

TACE for liver NET metastases (222 patients)

✅Median TTLP 19.3 mos
✅Median OS 5.3 yrs
✅OS ⬆️ in mRECIST responders (80.5 vs. 39.6 mos).
✅ Age, grade, liver involvement predict worse OS

Awesome study in @MDPIOpenAccess @GustaveRoussy @Beaujon_Rad https://t.co/buWT3p01rT

[Maxime Ronot @maximeronot]

Cystic Fibrosis-related liver disease (2/2)
“red-flag” features to suspect PSVD in pts with PHT
1⃣ no liver anomalies
2⃣ LSM < threshold for cirrhosis
3⃣ coarse macronodular pattern

Great review by J. Dana, V. Vilgrain @Beaujon_Rad in @JHepatology https://t.co/wvknF2yla7

[Maxime Ronot @maximeronot]

Cystic Fibrosis-related liver disease (1/2)
✅ PHT=main complication due to cirrhosis or PSVD
✅ US=key for diagnosis + follow-up
✅ Liver stiffness measurement may be helpful

Great review by J. Dana, V. Vilgrain @Beaujon_Rad in @JHepatology https://t.co/wvknF2yla7 #livertwitter

[Maxime Ronot @maximeronot]

Colonic involvement in Acute Mesenteric Ischemia
1⃣ found in 28%
2⃣ most common in the right colon
3⃣ increased morbidity (SBS, PS) and mortality
➡️ should be searched for on CT!
@inteststroke @AlexandreNuzzo @oliviercorcos @Beaujon_Rad @dr_manuweiss
https://t.co/cMDpI7oZpM

[Maxime Ronot @maximeronot]

Follow up of benign nodules in Budd Chiari or after Fontan with MRI

✅ 40% disappear
✅ 45% change in size and/or signal intensity
✅ changes in BCS >> Fontan
➡️ dynamics to be aware of !

@marco_dioguardi @RautouE @Beaujon_Rad #livertwitter
https://t.co/4NfEhcpLhe

[Maxime Ronot @maximeronot]

In patients with #NOMI no bowel enhancement, bowel thinning, bicarbonate ≤15 mM and PT <40%

1⃣Stratify the risk of bowel necrosis
2⃣> @inteststroke score by @AlexandreNuzzo

Great study by P. Calame in @AmJGastro
Proud to be part of it !
https://t.co/GZcN1Dpdjn

[Beaujon Radiology @Beaujon_Rad]

@maximeronot Concerning ! Any idea @ThatKevinSmith @theoneringnet ?

[Maxime Ronot @maximeronot]

@EASLnews what’s going on? Suddenly my tweeter feed is populated by hepatologists from all around the world excited like kids going to the theme park for the day! #ILC2021 Communicating energy! Enjoy!

[Beaujon Radiology @Beaujon_Rad]

A walk along the path of imaging for the diagnosis and prognosis of #HCC with @Riccard49700689 @Jules_GREGORY_ @marco_dioguardi and @maximeronot published in @LiverInt Stimulating !! https://t.co/iLsgEeY4il

[Beaujon Radiology @Beaujon_Rad]

55-yo male patient with chronic HBV infection but no cirrhosis. Surveillance US exam shows a 20mm nodule in the left liver lobe. The patient undergoes MRI for characterization. Simple question : am I allowed to call or an HCC ? @RadiologieUNIR #liver

[Beaujon Radiology @Beaujon_Rad]

Check the super useful presentation by @Marco_dioguardi about tips and tricks to access the inaccessible lesions at #Esgar2021. Available on-demand

[Beaujon Radiology @Beaujon_Rad]

Today @VChernyakMD and @ClaudeSirlin (with a bit of help from #Shakespeare) gave the most impressive, fun and educational duet lecture about #LIRADS at #esgar2021 Make sure to watch it’ available on-demand

[Beaujon Radiology @Beaujon_Rad]

Make sure to watch the great post-graduate course on Benign liver tumors with Valérie Vilgrain @giubrancatelli @valerie_paradis and Raneem Albazaz at #esgar2021. Available on-demand !!

[Hepatoma Research @HepatomaRes]

#surveillance #HCC #MRI Good article about "Alternative approach of hepatocellular carcinoma surveillance: abbreviated MRI" from Dr. Robert M. Marks's team. @RyanBrunsing @chemshift1 @bobmarks76 @ClaudeSirlin @VChernyakMD
Download for free: https://t.co/e7qunLhC6Y

[Beaujon Radiology @Beaujon_Rad]

Teduglutide induces a significant SB wall thickness ⬆️ that can be depicted by imaging <6 mo after treatment initiation. The degree of such ⬆️ may be associated with clinical response. Check out study in @AJCNutrition with @maximeronot and @franciscajoly https://t.co/NlTHSvw5xx

[Beaujon Radiology @Beaujon_Rad]

Found of quantitative imaging? We are too! With @Riccard49700689 we quantified the Pancreas Surface Lobularity on CT and found it to ⬆️ with age and BMI and to be > in men. Stimulating perspectives. Check out study in KJR https://t.co/6siiofI7vH

[Dr. Glaucomflecken @DGlaucomflecken]

Faculty meeting